References
- Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol Sep 2006; 92(1):60-4; PMID:16563470; http://dx.doi.org/10.1016/j.pbiomolbio.2006.02.020
- Munger KL, Kochert K, Simon KC, Kappos L, Polman CH, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, et al. Molecular mechanism underlying the impact of vitamin D on disease activity of MS. Ann Clin Transl Neurol Aug 2014; 1(8):605-17; PMID:25285313; http://dx.doi.org/10.1002/acn3.91
- Sundaram ME, Talbot HK, Zhu Y, Griffin MR, Spencer S, Shay DK, Coleman LA. Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old. Vaccine 2013; 31(16):2057-61; PMID:23453766; http://dx.doi.org/10.1016/j.vaccine.2013.02.028
- Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Serum 25-hydroxyvitamin D level and influenza vaccine immunogenicity in children and adolescents. PloS One 2014; 9(1):e83553; PMID:24427274; http://dx.doi.org/10.1371/journal.pone.0083553
- Zitt E, Sprenger-Mahr H, Knoll F, Neyer U, Lhotta K. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney. Vaccine Jan 20 2012; 30(5):931-5; PMID:22142584
- Heine G, Drozdenko G, Lahl A, Unterwalder N, Mei H, Volk HD, Dörner T, Radbruch A, Worm M. Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr Mar 2011; 65(3):329-34; PMID:21224870; http://dx.doi.org/10.1038/ejcn.2010.276
- Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract Jul–Aug 2009; 15(5):438-49; PMID:19491064; http://dx.doi.org/10.4158/EP09101.ORR
- Lin CJ, Zimmerman RK, Nowalk MP, Huang HH, Raviotta JM. Randomized controlled trial of two dosing schedules for human papillomavirus vaccination among college age males. Vaccine Feb 3 2014; 32(6):693-9; PMID:24342252; http://dx.doi.org/10.1016/j.vaccine.2013.11.098
- Dias D, Van Doren J, Schlottmann S, Kelly S, Puchalski D, Ruiz W, Boerckel P, Kessler J, Antonello JM, Green T, et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol Aug 2005; 12(8):959-69; PMID:16085914
- Holick MF, Binkley NC, Bischoff-Ferrari HAs, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab Jul 2011; 96(7):1911-30; PMID:21646368; http://dx.doi.org/10.1210/jc.2011-0385
- Hillman RJ, Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Vardas E, Aranda C, Jessen H, Ferris DG, Coutlee F, et al. Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old. Clin Vaccine Immunol Feb 2012; 19(2):261-7; PMID:22155768; http://dx.doi.org/10.1128/CVI.05208-11
- Linder N, Abudi Y, Abdalla W, Badir M, Amitai Y, Samuels J, Mendelson E, Levy I. Effect of season of inoculation on immune response to rubella vaccine in children. J Trop Pediatr Aug 2011; 57(4):299-302; PMID:19889749; http://dx.doi.org/10.1093/tropej/fmp104
- Lang PO, Aspinall R. Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response? Nutrients Mar 2015; 7(3):2044-60; PMID:25803545; http://dx.doi.org/10.3390/nu7032044
- Schiller JT, Lowy DR. Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials. J Infect Dis Jul 2009; 200(2):166-71; PMID:19519255; http://dx.doi.org/10.1086/599988
- Brown D, Muller M, Sehr P, Pawlita M, Seitz H, Rubio I, Antonello J, Radley D, Roberts C, Saah A. Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomavirus types 16 and 18. Vaccine Oct 7 2014; 32(44):5880-7; PMID:25148777; http://dx.doi.org/10.1016/j.vaccine.2014.08.004
- Zimmerman RK, Nowalk MP, Lin CJ, Fox DE, Ko FS, Wettick E, Cost G, Hand L, Hayes J, Michaels M. Randomized trial of an alternate human papillomavirus vaccine administration schedule in college-aged women. J Womens Health (Larchmt) Aug 2010; 19(8):1441-7; PMID:20629576; http://dx.doi.org/10.1089/jwh.2009.1753